Ratings as of Thursday 12 November 2026 · updated after every US close
Relative Strength
An RS rating of 95 means the stock out-performed 95% of the rated stocks (William O'Neil's method). The score weights the last 3 months most (40%), then 6, 9 and 12 months (20% each), counted in trading days. Rated stocks are US common stocks and ADRs worth $300M or more, with an average price above $5 over 50 days, enough trading volume and at least 12 months of trading. This page shows who leads, who is new, who is climbing or slipping, and whether the price still looks buyable.
2,729rated276leaders at 90+28new today25coasting
▲Who is rising
New in the top tiers
12 entered 95+ · 16 entered 90+
Biggest RS jumps today
RS points gained in one day
30-day climbers
often the next 90+ names
▼Who is slipping
Coasting leaders
25 of 276 rated 90+ on old gains
3-month return in the bottom 40%
Leaders losing strength
56 of 276 fell over 30 days
Biggest RS drops today
RS points lost in one day
2,729 stocks
Below 90
2,453
90–94
138
95+
138
The 90+ tier is one in ten stocks. Everything here focuses on it.
97 92 85 60 RS tiers: 95+, 90–94, 80–89, below 80
Returns strip: 1m · 3m · 6m · 9m · 12m as percentiles. Green only on the right means coasting on old gains.
Setup check: within 15% of the 52-week high, above the 50-day and the 200-day average.
Days at 90+ counts the current unbroken streak in the leaders' tier.
Leaders momentum
which way the leaders are heading over 30 daysHow each tier moved over 30 days
RS 95+138 stocks95 rising202369% up
RS 90–94138 stocks99 rising63372% up
▲ Gaining fastestRS points in 30 days · now
▼ Fading fastestleaders whose RS fell most
Bar = RS points gained or lost over 30 days · line = the RS rating over those days · badge = the rating now. Click a row to open it below.
Where the leaders are
industries by number of RS 90+ stocks · click to filterIndustryshare of 90+StocksAvg
Top 10 industries · green part of the bar = RS 95+ · 24 of the 276 leaders have no industry on file
Size of the leaders
RS 90+ stocks by market capMega (>$200B)4
Large ($10–200B)46
Mid ($2–10B)118
Small (<$2B)108
Leadership is broad when mid and small caps hold most of the 90+ list, and narrow when it sits in a few mega caps. Dark green is the 95+ share.
Rankings
#CompanyTrend 30d
1MRNAModerna, Inc. Common Stock9923d+· 0· 0-17.6%2/34899999999Biological Products, (No Disgnostic Substances)1d · 030d · 0
2SYRESpyre Therapeutics, Inc. Common Stock9923d+· 0▲ 2-7.0%3/39663859999Pharmaceutical Preparations1d · 030d ▲ 2
3HNGESHinge Health, Inc.9923d+· 0▲ 2-4.3%3/38497989998Services-Computer Processing & Data Preparation1d · 030d ▲ 2
4TXGS10x Genomics, Inc. Class A Common Stock9923d+· 0· 0-42.5%1/3976999999Laboratory Analytical Instruments1d · 030d · 0
5TWSTTwist Bioscience Corporation Common Stock9923d+· 0· 0-48.0%1/3655989899Biological Products, (No Disgnostic Substances)1d · 030d · 0
6ORKAOruka Therapeutics, Inc. Common Stock9923d+· 0▲ 3-9.1%3/39749949999Pharmaceutical Preparations1d · 030d ▲ 3
7KODKodiak Sciences Inc Common Stock9923d+· 0· 0-3.6%3/39799999999Biological Products, (No Disgnostic Substances)1d · 030d · 0
8ERASErasca, Inc. Common Stock9923d+· 0▲ 1-35.0%2/36529917799Pharmaceutical Preparations1d · 030d ▲ 1
9CDNACaredx, Inc.9923d+· 0· 0-12.2%3/39399999999Services-Medical Laboratories1d · 030d · 0
10ABCLAbcellera Biologics Inc. Common Shares9923d+· 0· 0-22.6%1/32669999998Pharmaceutical Preparations1d · 030d · 0
11IOVAIovance Biotherapeutics, Inc. Common Stock9923d+· 0· 0-50.4%1/3282989998Biological Products, (No Disgnostic Substances)1d · 030d · 0
12XERSXeris Biopharma Holdings, Inc. Common Stock997d· 0▲ 14-1.3%3/39999999897Pharmaceutical Preparations1d · 030d ▲ 14
13XNCRXencor, Inc.9923d+· 0▲ 4-6.1%3/39999999998Pharmaceutical Preparations1d · 030d ▲ 4
14SDGRSchrodinger, Inc. Common Stock9923d+▲ 1▲ 5-9.3%3/39399999890Pharmaceutical Preparations1d ▲ 130d ▲ 5
15REPLReplimune Group, Inc.9923d+· 0· 0-6.6%3/39998999897Biological Products, (No Disgnostic Substances)1d · 030d · 0
16AGLAgilon Health, Inc.9923d+· 0· 0-17.1%2/39588889999Services-Misc Health & Allied Services, Nec1d · 030d · 0
17ETONSEton Pharmaceutcials, Inc. Common Stock9923d+· 0▲ 1-13.0%3/38574989999Pharmaceutical Preparations1d · 030d ▲ 1
18ATEXAnterix Inc. Common Stock9923d+▲ 1▲ 1-26.8%2/33838899899Telephone Communications (No Radiotelephone)1d ▲ 130d ▲ 1
19ABSIAbsci Corporation Common Stock9923d+· 0▲ 1-27.2%1/35564949998Services-Commercial Physical & Biological Research1d · 030d ▲ 1
20SGSweetgreen, Inc.9923d+· 0▲ 9-10.9%3/39299969897Retail-Eating Places1d · 030d ▲ 9
21SLNSilence Therapeutics Plc American Depository Share9919d· 0▲ 16-0.3%3/39998999999Pharmaceutical Preparations1d · 030d ▲ 16
22CLYMClimb Bio, Inc. Common Stock9923d+· 0▲ 1-40.7%1/3589399699Pharmaceutical Preparations1d · 030d ▲ 1
23TOPTop Financial Group Limited Class A Ordinary Shares9923d+· 0· 0-11.4%3/35098999998–1d · 030d · 0
24OPRTOportun Financial Corporation Common Stock9923d+▲ 1▲ 4-11.8%3/39799989798Finance Services1d ▲ 130d ▲ 4
25FOSLFossil Group, Inc.9923d+· 0▲ 1-17.2%2/39599989799Watches, Clocks, Clockwork Operated Devices/Parts1d · 030d ▲ 1
26TKNOAlpha Teknova, Inc. Common Stock9916d· 0▲ 2-12.5%3/36187989990In Vitro & In Vivo Diagnostic Substances1d · 030d ▲ 2
27RCELAvita Medical, Inc. Common Stock9923d+· 0· 0-12.1%3/39399999999Surgical & Medical Instruments & Apparatus1d · 030d · 0
28TTRXTurn Therapeutics Inc. Common Stock9917d+· 0▲ 2-38.4%1/32177999898–1d · 030d ▲ 2
29OKTAOkta, Inc. Class A Common Stock9823d+▲ 1· 0-22.3%1/31494999796Services-Prepackaged Software1d ▲ 130d · 0
30GKOSGlaukos Corporation9822d· 0▲ 10-3.6%3/39997959798Surgical & Medical Instruments & Apparatus1d · 030d ▲ 10
1–30 of 2,729Page 1 of 91